Moxidectin

莫昔克丁

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameMoxidectin
Drug Alias NameMilbemycin BMoxidectinCL-301423
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate-gated chloride channel modulators
TargetsGlutamate-gated chloride channel
Therapy Area/IndicationsScabiesOnchocerciasisInfections
Global Approved IndicationsOnchocerciasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2018/06/13
Country/TerritoryUnited StatesEl SalvadorAustralia +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedicines Development For Global Health Ltd
Inactive CompaniesWyeth LlcPfizer Inc
Active IndicationsScabiesOnchocerciasis
Inactive IndicationsInfections

Other Information

ATC CodeP02CX03
Related LinksWikipediaDrugBankKEGG